Clicky

Dare Bioscience, Inc.(DARE)

Description: Dare Bioscience, Inc., formerly Cerulean Pharma Inc., is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is developing Ovaprene to provide protection over multiple weeks of use and require no intervention at the time of intercourse. Ovaprene has a custom intravaginal ring design, with a permeable mesh in the center of the ring that creates a partial barrier to sperm, and a mechanism to release locally acting spermiostatic agents through the ring. The combination of these two complementary approaches produces attractive contraceptive efficacy outcomes that are consistent with the effective barrier option, the diaphragm, and short-acting hormonal options, such as oral pill, patches and vaginal ring.


Keywords: Medicine Drugs Vagina Medroxyprogesterone Acetate Women's Health Diaphragm Birth Control Hormonal Contraception Reproductive Health

Home Page: www.darebioscience.com

DARE Technical Analysis

3655 Nobel Drive
San Diego, CA 92122
United States
Phone: 858 926 7655


Officers

Name Title
Ms. Sabrina Martucci Johnson Pres, CEO, Sec. & Director
Ms. Lisa Walters-Hoffert Chief Financial Officer
Mr. John A. Fair Chief Strategy Officer
Mr. Mark Walters VP of Operations
Ms. MarDee J. Haring-Layton VP of Accounting & Fin.
Dr. David Friend Chief Scientific Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 2.8971
Price-to-Sales TTM: 7.6682
IPO Date: 2014-04-10
Fiscal Year End: December
Full Time Employees: 20
Back to stocks